Schedule 13D ownership disclosure

AEVI GENOMIC MEDICINE INC

Security class unavailable · CUSIP: 00835P105

Event date: 2019-12-05

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
52.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-19-070689
Form type
SC 13D/A
Filer
Aevi Genomic Medicine, LLC
CIK
CIK 1138776
Filed
Dec 06, 2019
Reporting period
Dec 05, 2019
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub